Trial · NCT01736852

Evaluation of CRB in PROM Patients

NCT01736852, Not applicable, Completed, Cook Group Incorporated; results first posted 2020-10-20

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Evaluation of CRB in PROM Patients. Trials, record NCT01736852. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01736852

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Evaluation of CRB in PROM Patients
NCT number: NCT01736852
Status: Completed
Phases: Not applicable
Enrollment: 129 participants, actual
Lead sponsor: Cook Group Incorporated
Conditions: Premature Rupture of Fetal Membranes
Interventions: CRB, Pitocin
First posted: 2012-11-29
Last updated: 2020-10-20
Results first posted: 2020-10-20

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Time of Labor	Start of labor induction through delivery, an expected average of 6 hours	Time, in minutes, from the start of labor induction through delivery
Primary	Incidence of Infection	Through hospital discharge, an expected average of 3 days	number of patients with chorioamnionitis

Source ClinicalTrials.gov

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Time of Labor	Start of labor induction through delivery, an expected average of 6 hours		Minutes	MEAN
PRIMARY	Incidence of Infection	Through hospital discharge, an expected average of 3 days		Participants	COUNT_OF_PARTICIPANTS

Source ClinicalTrials.gov

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Value	Spread	Units
Time of Labor	CRB Plus Pitocin	850.4	Standard Deviation 417.6	Minutes
Time of Labor	Pitocin	1016.6	Standard Deviation 595.7	Minutes
Incidence of Infection	CRB Plus Pitocin	7		Participants
Incidence of Infection	Pitocin	6		Participants

Source ClinicalTrials.gov

Participant flow6

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	CRB Plus Pitocin	65
Overall Study	STARTED	Pitocin	64
Overall Study	COMPLETED	CRB Plus Pitocin	63
Overall Study	COMPLETED	Pitocin	61
Overall Study	NOT COMPLETED	CRB Plus Pitocin	2
Overall Study	NOT COMPLETED	Pitocin	3

Source ClinicalTrials.gov

Adverse events20

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events
other	Arrested Labor	Pregnancy, puerperium and perinatal conditions	CRB Plus Pitocin	7	63	7
other	Arrested Labor	Pregnancy, puerperium and perinatal conditions	Pitocin	13	61	13
other	Amniotic Cavity Infection	Infections and infestations	CRB Plus Pitocin	7	63	7
other	Amniotic Cavity Infection	Infections and infestations	Pitocin	6	61	6
other	Jaundice Neonatal	Pregnancy, puerperium and perinatal conditions	CRB Plus Pitocin	14	63	14
other	Jaundice Neonatal	Pregnancy, puerperium and perinatal conditions	Pitocin	5	61	5
serious	Jaundice Neonatal	Pregnancy, puerperium and perinatal conditions	CRB Plus Pitocin	1	63	1
serious	Jaundice Neonatal	Pregnancy, puerperium and perinatal conditions	Pitocin	1	61	1
serious	Neonatal Hypoxia	Respiratory, thoracic and mediastinal disorders	CRB Plus Pitocin	0	63	0
serious	Neonatal Hypoxia	Respiratory, thoracic and mediastinal disorders	Pitocin	1	61	1

1 to 10 of 20Source ClinicalTrials.gov

See all 20 adverse events

Adverse event totals6

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	CRB Plus Pitocin	0	63
Total, all-cause mortality	Pitocin	0	61
Total, other adverse events	CRB Plus Pitocin	27	63
Total, other adverse events	Pitocin	21	61
Total, serious adverse events	CRB Plus Pitocin	5	63
Total, serious adverse events	Pitocin	4	61

Source ClinicalTrials.gov

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as
42424638	DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison	Source
CRB Plus Pitocin vs Pitocin: Incidence of Infection	Trial comparisons
CRB Plus Pitocin vs Pitocin: deaths from any cause	Trial comparisons
CRB Plus Pitocin vs Pitocin: serious adverse events	Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01736852

GET https://conductscience.org/api/trials/v1/NCT01736852/registered

API reference For AI assistants